Canagliflozin Attenuates PromarkerD Diabetic Kidney Disease Risk Prediction Scores.

J Clin Med · 2023 · PMC10179173 · PMID 37176686

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Canagliflozin was also associated with decreased PromarkerD scores for those in the moderate-risk category (Δ score: −2.7% [−6.1%, 0.8%]), although this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.